KAA Pep-LNP

Cat. No.: TDLD-0825-LD103

KAA Pep-LNP

KAA Pep-LNP is a state-of-the-art peptide-functionalized lipid nanoparticle (LNP), designed for efficient targeted delivery of therapeutic cargoes such as siRNA, mRNA, DNA, small molecule drugs, and RNA-guided gene editing systems. Engineered with the FKAA peptide, this LNP specifically recognizes and binds to unique markers expressed on pancreatic cancer cells, enabling precise localization of the therapeutic payload directly to the tumor site. Our LNP is prepared using DSPE-PEG-KAA and a variety of optional lipid formulations including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and others. These formulations are carefully selected to ensure the LNP has uniform particle size, high encapsulation efficiency, stability, and targeted delivery. Applications of KAA Pep-LNP include developing highly specific pancreatic cancer therapeutics, creating targeted imaging agents for pancreatic tumors, studying the biology of pancreatic cancer cell markers, and evaluating novel strategies for selective pancreatic cancer treatment. Please note that this product is intended for research purposes only.